For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
DELFIA® Eu-Labeled Anti-Human IgG is intended for use as a secondary antibody in various types of immunoassay based on solid-phase separation. The label, Eu3+, is measured using dissociation-enhanced time-resolved fluorometry.
The products are made from in vitro produced and affinity-purified mouse monoclonal IgG2b antibody specific for the Fc-part of human IgG. The antibodies recognize all IgG subclasses and cross-react with rabbit immunoglobulins.
This product is supplied ready-to-use in 50 mmol/L Tris-HCl buffered saline solution. As a general guideline for DELFIA® immunoassays, a final concentration of 100 ng/mL of the anti-human IgG antibodies may be suitable for generation of the signal.
|Antibody Conjugates||Anti-human IgG|
|Detection Method||Time-Resolved Fluorescence (TRF), DELFIA TRF|
|Experimental Type||In vitro|
|Product Brand Name||DELFIA|
|Shipping Condition||Blue Ice|
|Unit Size||100 µg|
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater assay throughput and sensitivity has evolved. In response, more robust immunoassays have been developed to address some of the limitations of the standard, colorimetric ELISA.
Find out about the most common limitations of traditional ELISAs and how different ELISA alternative technologies address these limitations.
DELFIA Eu-labelled Anti-Human IgG is intended for use as a secondary antibody in various types of immunoassay based on solid-phase separation.